A case of vancomycin‐induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180
暂无分享,去创建一个
[1] H. Koga,et al. IgA anti-p200 pemphigoid. , 2011, Archives of Dermatology.
[2] T. Hashimoto,et al. IgA autoantibodies against the NC16a domain of BP180 but not 120‐kDa LAD‐1 detected in a patient with linear IgA disease , 2008, The British journal of dermatology.
[3] Amin Fazeli,et al. Vancomycin‐induced linear IgA disease manifesting as bullous erythema multiforme , 2004, Journal of cutaneous pathology.
[4] D. Zillikens,et al. The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N-termini. , 2003, The Journal of investigative dermatology.
[5] G. Ogg,et al. Vancomycin‐induced linear IgA disease with autoantibodies to BP180 and LAD285 , 2001, The British journal of dermatology.
[6] H. Hennies,et al. Evidence for a single genetic locus in Clouston's hidrotic ectodermal dysplasia , 1999, The British journal of dermatology.
[7] E. Bröcker,et al. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. , 1998, The Journal of investigative dermatology.
[8] Allen,et al. Drug‐induced linear IgA disease with antibodies to collagen VII , 1998, The British journal of dermatology.
[9] J. Roujeau,et al. Drug‐induced linear IgA disease: target antigens are heterogeneous , 1997, The British journal of dermatology.
[10] H. Shimizu,et al. A case of linear IgA buUous dermatosis with IgA anti‐type VII collagen autoantibodies , 1996, The British journal of dermatology.